Randox Laboratories: against COVID-19 Company
Entity: Randox
Category: Test Kits
Description: Randox is an international clinical diagnostic solutions company. Randox is a global leader in healthcare diagnostics; today more than 5% of the world’s population – in excess of 370 million people across 145 countries – receives medical diagnosis using Randox products each year. Randox is the largest diagnostic company from the UK and exports over 95% of products worldwide. Their products and services are used in hospitals, clinical, research and molecular laboratories, food testing, forensic toxicology, life sciences, and veterinary laboratories.
Project: VRI Array
Summary: Randox has developed a rapid test for COVID-19 (SARS-CoV-2), the new strain of coronavirus. The test is currently available on a laboratory-based system which tests up to 324 samples in 8 hours. Randox are working with Bosch Healthcare to make available a point of care test which can give results in less time. This game-changing Viral Respiratory Tract Infection (VRI) Array is available on The Vivalytic, a molecular point-of-care platform brought to the market by Randox Laboratories and leading technology manufacturer Bosch Healthcare Solutions. The revolutionary VRI Array can identify SARS-CoV-2 and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses. Also available is the COVID-19 Array which detects the SARS-CoV-2 virus as well as sarbecovirus (SARS, SARS Like, SARS-CoV-2) ensuring accurate diagnosis. Utilising patented Randox Biochip Technology, 54 patient samples and 540 test results can be processed in less than 5 hours on the Randox Evidence Investigator, a semi-automated analyser.
Category: Test Kits
Description: Randox is an international clinical diagnostic solutions company. Randox is a global leader in healthcare diagnostics; today more than 5% of the world’s population – in excess of 370 million people across 145 countries – receives medical diagnosis using Randox products each year. Randox is the largest diagnostic company from the UK and exports over 95% of products worldwide. Their products and services are used in hospitals, clinical, research and molecular laboratories, food testing, forensic toxicology, life sciences, and veterinary laboratories.
Project: VRI Array
Summary: Randox has developed a rapid test for COVID-19 (SARS-CoV-2), the new strain of coronavirus. The test is currently available on a laboratory-based system which tests up to 324 samples in 8 hours. Randox are working with Bosch Healthcare to make available a point of care test which can give results in less time. This game-changing Viral Respiratory Tract Infection (VRI) Array is available on The Vivalytic, a molecular point-of-care platform brought to the market by Randox Laboratories and leading technology manufacturer Bosch Healthcare Solutions. The revolutionary VRI Array can identify SARS-CoV-2 and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses. Also available is the COVID-19 Array which detects the SARS-CoV-2 virus as well as sarbecovirus (SARS, SARS Like, SARS-CoV-2) ensuring accurate diagnosis. Utilising patented Randox Biochip Technology, 54 patient samples and 540 test results can be processed in less than 5 hours on the Randox Evidence Investigator, a semi-automated analyser.
Technology:
Test Kits
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership